Every allegation below carries its verdict, its reasoning and a link to the source document.
There are 53 of them, and the entries unfavourable to the protocol's author are included and marked.
Each row has a permanent anchor: link to #C01 to cite one specific claim.
Jump to: Substance & chemistry · Harm & toxicity · Regulators & agencies · Efficacy & evidence · Personal accusations · Legal & judicial · Media & fact-checkers · Substance & chemistry
| ID | Claim | Verdict | Reason | Source |
|---|---|---|---|---|
| Substance & chemistry — 5 | ||||
C01updated 2026-10-20 |
CDS is bleach. Related: C02 C03 |
FALSE | Household bleach is sodium hypochlorite (NaClO). CDS is chlorine dioxide (ClO2) gas dissolved in water: a neutral solution with no sodium and no hydroxide. Sodium chlorite (NaClO2) is a third substance. | ATSDR Toxicological Profile for Chlorine Dioxide and Chlorite (TP-160) — primary, CAS 10049-04-4 / 7758-19-2 copy |
C02updated 2026-10-20 |
MMS and CDS are the same product. Related: C01 C03 |
PARTLY FALSE | MMS is the reacting mixture — sodium chlorite acidified before ingestion — drunk as such. CDS uses the same source reaction, but the chlorine dioxide generated is drawn off as gas and dissolved in water, leaving the acid and residual chlorite in the generator. The difference is what ends up in the final product, and therefore what is ingested. | ATSDR TP-160 — primary copy |
C03updated 2026-10-20 |
A 25% chlorine dioxide solution caused hepatotoxicity. Related: C01 C09 |
CHEMICALLY IMPOSSIBLE AS STATED | Dissolved ClO2 cannot exceed about 0.6-0.8% w/v, so a 25% product is sodium chlorite. In the published case the dilution volume was not recorded, fever preceded exposure, recovery was complete by day 8 and no methemoglobinemia was found. | Brandariz-Nunez D, et al. Toxicity induced by chlorine dioxide — case, Farm Hosp 2022;46(5):308-310 copy |
C04updated 2026-10-20 |
It lacks the redox potential to injure tissue. Related: C03 |
WITHDRAWN — CHEMICALLY WRONG | The claim as stated is wrong and is withdrawn: chlorine dioxide (+0.95 V for ClO2/ClO2-) is not among the strongest oxidants and sits below the O2/H2O couple (+1.229 V at pH 0; ≈+0.82 V at pH 7.4, where the two become comparable). But the correct argument is not about potential: dissolved ClO2 cannot exceed ~6-8 g/L, and the oxidising equivalents delivered by a small volume of dilute solution are trivial against mucosal reducing capacity. The hydroxyl radical (≈+2.3 V) is far above both and is the true agent of oxidative tissue damage. | US EPA - ORP, oxidant and pH in drinking water — primary copy |
C05updated 2026-10-20 |
Chlorine dioxide is 30 times more toxic than bleach. Related: C01 |
INVERTED | EPA oral LD50 for chlorine dioxide is 292 mg/kg (male rat) and 340 mg/kg (female). Published hypochlorite LD50s are in the hundreds to thousands of mg/kg depending on concentration. For a 70 kg adult, 292 mg/kg means 20.4 g, which requires about 6.8 litres of 0.3% stock. | US EPA, Chlorine Dioxide Final Risk Assessment — primary, Case 4023 (EPA-HQ-OPP-2006-0328-0017) copy |
| Harm & toxicity — 12 | ||||
C06updated 2026-10-20 |
The FDA records deaths from drinking chlorine dioxide. Related: C07 C08 |
NOT SUPPORTED | The complete FAERS set indexed to 'chlorine dioxide' is 8 reports: no dose, no verified substance, no death, no methemoglobinemia, and no attributable event once the codeine confounder is accounted for. Reports indexed to 'sodium chlorite' total 16, of which three are relevant, including one suicide attempt. | openFDA Drug Adverse Event API — dataset, 8 + 16 reports copy |
C07updated 2026-10-20 |
Chlorine dioxide causes methemoglobinemia. Related: C06 |
NOT DOCUMENTED AT PROTOCOL CONCENTRATION | No methemoglobinemia appears in FAERS under chlorine dioxide. Published laboratory-confirmed cases involve a household cleaning product ingested by a child (MetHb 8.0%) or undiluted 28% sodium chlorite. | Hagiwara Y, Inoue N. First case of methemoglobinemia caused by a ClO2-based household product — case, PMID 26338044 copy |
C08updated 2026-10-20 |
A child died in Argentina from chlorine dioxide. Related: C07 C09 |
NOT ESTABLISHED AS A CAUSAL FINDING | The forensic board wrote that findings were 'compatible' and noted that pathological and toxicological studies remained to be performed. The criminal case closed in 2021 without conviction: the prosecution's proof of ingestion rested only on the parents' statements, which the judge held inadmissible for that purpose. | Ministerio Publico Fiscal de Neuquen, 'Los hallazgos son compatibles...' — primary, 27-08-2020 copy El Cordillerano, parents to be dismissed — press, 07-10-2021 copy |
C09updated 2026-10-20 |
It damages the thyroid and neurodevelopment. Related: C06 |
PARTLY TRUE, AT HIGH CONTINUOUS DOSE IN ANIMALS | Bercz et al. (1982) reported reversible T4 depression in African green monkeys. The paper measured water consumption: ≈125 mL/kg/day in controls, ≈95 at 100 mg/L and ≈55 at 200 mg/L, where the stage was terminated after one week because of oral injury. At 100 mg/L the authors state the T4 depression was statistically related to both consumption and dose and that, intake being near normal, it cannot be explained by dehydration. Residual objection, stated fairly: a ~25% fall in intake and no pair-water control mean a contribution from reduced intake cannot be excluded, so the finding is weakened as a quantitative estimate, not invalidated. The 200 mg/L stage must never be cited as tolerated intake. | Bercz JP et al., Subchronic toxicity of chlorine dioxide in the nonhuman primate (full text) — study, Environ Health Perspect 1982;46:47-55 · PMC1569048 copy ATSDR TP-160, animal toxicology — primary copy Bercz JP et al. Mechanistic aspects of ingested chlorine dioxide on thyroid function — study, Environ Health Perspect 1986 copy |
C10updated 2026-10-20 |
Concentrated chlorite is harmless. Related: C03 C07 |
FALSE — NOT CLAIMED | Concentrated chlorite products can cause serious injury and must not be drunk. This register does not dispute it. Published serious cases involve 25-28% products, undiluted ingestion, intravenous administration or domestic accidents. | Arnold et al. 2018 - ingestion of ~75 mL of 28% sodium chlorite — case, case report copy |
C29updated 2026-10-20 |
Since Bolivia authorised use by law, there have been severe poisonings or deaths from CDS there. Related: C25 C06 C08 |
NO CASE LOCATED — NEGATIVE EVIDENCE | Searches on 20 October 2026 in Spanish- and English-language news, PubMed and Bolivian official sources (minsalud.gob.bo, AGEMED) returned no report or published case attributing severe poisoning or death to CDS in Bolivia after Ley 1351 came into force in December 2020. AGEMED's public warning on chlorine dioxide is dated 27 June 2020, i.e. before the law. This is negative evidence, not proof of absence: absence of publication is not absence of occurrence, and Bolivia's pharmacovigilance reporting is incomplete. Any documented case will be added here. | AGEMED / Ministerio de Salud y Deportes de Bolivia — warning on chlorine dioxide — primary, 27-06-2020 copy Gaceta Oficial de Bolivia, Ley N° 1351 — primary, ed. 1336NEC, 01-12-2020 copy |
C32updated 2026-10-20 |
There are no animal safety studies of chlorine dioxide. Related: C12 C13 |
FALSE | Ma JW et al., Int J Environ Res Public Health 2017;14(3):329 (PMID 28327506) report a subchronic oral toxicity test in which up to 40 ppm of chlorine dioxide in drinking water produced no toxicity, together with inhalation (20 ppm, 24 h), ocular (50 ppm) and cytotoxicity data (93.7% L929 viability at 200 ppm). The authors are affiliated with the manufacturer of the product tested, which is disclosed here; the study is animal and in vitro data, not a clinical trial. | Ma JW et al., Efficacy and Safety Evaluation of a Chlorine Dioxide Solution — study, IJERPH 2017;14(3):329 · PMID 28327506 copy |
C41updated 2026-10-27 |
Symptoms after taking CDS are poisoning, not a Herxheimer reaction. Related: C06 C16 |
EMPIRICALLY UNRESOLVED | The term is used loosely in the community and cannot be verified case by case without measurement. What can be said: reported adverse reactions in the largest cohort were 6.78%, all mild; and symptoms during treatment may be the disease, the product, or neither. Attributing them to a 'die-off' is an interpretation, not a finding. | Aparicio-Alonso et al., J Infect Dis Ther 2021;9:477 — study, adverse reactions 6.78% copy |
C44updated 2026-10-27 |
CDS enemas are used on autistic children and cause harm. Related: C16 |
NO STUDY — AND A PRACTICE THIS REGISTER DOES NOT DEFEND | There is no published study of CDS in autism, in either direction, and no registry of harms. The practice of administering enemas to children is not supported by any controlled evidence and this register does not endorse it. Testimonial videos are not evidence of safety or efficacy in minors. | Dioxipedia — Controversia (allegation 16) — reference |
C46updated 2026-10-27 |
Advisers in the CDS community give dangerous advice. Related: C45 |
NOT VERIFIED — NO REGISTRY OF HARM | No published registry, case series or pharmacovigilance report documents harm caused by CDS advisers. Absence of a registry is not proof of absence. Context, stated as context and not as a rebuttal: iatrogenic harm is itself well documented — Makary & Daniel estimated 251,454 deaths a year in the US from medical error (BMJ 2016). That does not answer this allegation; it shows that 'unregulated advice is dangerous' applies widely. | Makary & Daniel, Medical error—the third leading cause of death in the US, BMJ 2016 — study, doi:10.1136/bmj.i2139 |
C52updated 2026-10-27 |
CDS dosing is chaotic and nobody knows how much is being taken. Related: C01 C29 |
FALSE AS STATED | The arithmetic is exact: 10 ml of a 3,000 mg/L stock in 1,000 ml of water gives 30 mg of chlorine dioxide, which is 30 mg/L, i.e. 30 ppm. The protocols are defined in the published book. What is genuinely confused is third-party retelling, where 'ppm of the stock' and 'ppm ingested' are mixed, and where drops, millilitres and grams are used interchangeably. The protocol is precise; the discourse about it is not. The book itself states the equivalence explicitly — '10 ml of CDS at 3,000 ppm, or 100 ml of CDS at 300 ppm' — and both give the same amount: 30 mg. Two forms, one quantity, stated by the author. | Dioxipedia — Controversia (allegation 24) — reference Salud Conseguida — Protocol C, both concentration forms — book, 10 ml @ 3.000 ppm = 100 ml @ 300 ppm copy |
C53updated 2026-10-27 |
Thousands of people report having taken CDS on social media, and none of them reports death or serious harm. Related: C29 C45 C46 |
NEGATIVE EVIDENCE — LARGE CORPUS, NO VERIFICATION | What exists is a large corpus of self-reports, not a statistic: 293 documented cases in the Dioxipedia archive, transcripts of 5,568 distinct testimonial videos (40,858 indexed passages) and an uncounted volume of social-media comments. In that corpus we have located no account of death or serious harm attributed to CDS at protocol concentration. The limits are structural and stated here: nobody verifies what each person took or how much, people who died do not post, and the corpus is self-selected. Read against it, and not hidden: the only published multicentre series (eight Latin American poison centres, March–September 2020) records 56 cases and 3 deaths, all in the context of misuse of artisanal preparations of undetermined concentration, without separating CDS from chlorite. With no measured denominator, the absence of more published cases is weak negative evidence: it does not prove safety, and it does not support an epidemic that nobody has documented. | Dioxipedia testimonial archive (293 cases) — case-archive, 293 DioxiTube testimonial corpus, indexed transcripts — video-archive, 5,568 videos / 40,858 passages Saracco et al., Exposiciones a dióxido de cloro/clorito en América Latina, Acta Toxicol Argent 2020 — study, 56 casos, 3 fallecimientos |
| Regulators & agencies — 3 | ||||
C11updated 2026-10-20 |
The FDA's warnings rest on clinical evidence. Related: C06 |
UNSUPPORTED BY THE PUBLIC RECORD | The public basis is a set of spontaneous adverse-event reports of the quality documented here, plus enforcement over marketing claims. No dose-verified, substance-verified series at protocol concentration is cited. | openFDA FAERS — dataset copy |
C12updated 2026-10-20 |
Chlorine dioxide has never been tested in humans. Related: C13 |
FALSE | EPA-funded controlled studies gave chlorine dioxide and chlorite to 334 healthy adult males, including a 12-week chronic ingestion phase and a phase in G6PD-deficient subjects; the EPA review records a human NOAEL of 0.036 mg/kg/day. | Lubbers JR, et al. Controlled clinical evaluations of chlorine dioxide, chlorite and chlorate in man — study, Fundam Appl Toxicol 1981;1(4):334-338 copy |
C13updated 2026-10-20 |
There is no safe oral level. Related: C12 |
CONTRADICTED BY FEDERAL TOXICOLOGY | ATSDR derives an intermediate-duration oral minimal risk level of 0.1 mg/kg/day for chlorite from a NOAEL of 2.9 mg/kg/day. The MRL describes continuous exposure over 15-364 days, not a treatment course. | ATSDR TP-160, oral MRLs — primary copy |
| Efficacy & evidence — 15 | ||||
C14updated 2026-10-20 |
There is no evidence at all; it is pure pseudoscience. Related: C15 |
FALSE AS STATED | A PRISMA-adapted scoping review identified 34 studies (15 animal, 19 human), including six human clinical studies. 'No randomised trial' is a different statement and it is true. | Scoping review, chlorine dioxide efficacy and toxicity — review, LAJCLinSci copy |
C15updated 2026-10-20 |
A randomised trial proved it does not work. Related: C14 |
MISLEADING | The 2024 Osaka RCT tested a 0.01% aqueous mouthwash against salivary SARS-CoV-2 titre, not an ingested 0.3% solution against clinical outcomes. The rinse did not differ from placebo. | Osaka multicentre RCT — study, jRCTs031230566; J Evid Based Dent Pract 2024;24(4):102040 copy |
C16updated 2026-10-25 |
99.3% cure, with a confidence interval excluding trivial outcomes. Related: C14 |
OVERSTATED BY SUPPORTERS | The publication reports 99.07% discharged without complications, with no confidence interval and no comparator arm; the claim of a confidence interval excluding trivial outcomes is not in the paper and is withdrawn. But the 99.07% is the least informative figure in that cohort, and the register should say so: in outpatients mortality is an endpoint almost anything passes, and every patient was enrolled while symptomatic, not merely PCR-positive. The informative figure is time to symptom resolution — 4.84 days on average. For comparison, the US CDC reports that 35% of symptomatic outpatients had still not returned to their usual state of health 14 to 21 days after testing (MMWR 2020;69:993-998). Without a control arm, and with differing endpoint definitions, that is a hypothesis-generating comparison rather than proof of efficacy — and it is the number a controlled trial would have to address. | Aparicio-Alonso M, et al. Chlorine dioxide as an alternative treatment for COVID-19 — study, J Infect Dis Ther 2021;9:477 copy CDC MMWR — Symptom duration among outpatients with COVID-19 — cohort, MMWR 2020;69:993-998 |
C17updated 2026-10-20 |
Dilute CDS is proven effective. Related: C14 C16 |
NOT ESTABLISHED | No randomised controlled trial of ingested CDS against clinical endpoints exists. The evidence is consistent in direction but uniformly uncontrolled. | Evidence ladder — review copy |
C18updated 2026-10-20 |
All positive studies come from the same small circle. Related: C14 |
PARTLY TRUE — CONCEDED | The principal positive authors and the protocol's author have published together and acknowledge one another. Only independent replication answers this, and it does not yet exist. | Scoping review acknowledging the association — review copy |
C30updated 2026-10-20 |
A patent filing proves that the treatment works. Related: C14 C17 |
INVALID INFERENCE — IN BOTH DIRECTIONS | Swiss application 00506/20 was filed on 29 April 2020 for a «pharmaceutical composition for the treatment of Covid-19»; the IGE receipt certificate is published here. Three WIPO applications (WO2018185346/47/48) were published. A patent is granted for novelty, inventive step and industrial applicability — never for clinical efficacy — so a filing does not validate a treatment, and a refusal does not invalidate one. The applicant states the Swiss application was refused without stated grounds; that has not been verified, and the reasoned decision can be obtained from the IGE file or the representative. | IGE | IPI, Hinterlegungsbescheinigung for application 00506/20 — court, Anmeldedatum 29.04.2020 copy |
C34updated 2026-10-27 |
Liability insurance does not cover MMS-related damages. Related: C02 |
NOT VERIFIED | No policy wording, exclusion clause or insurer statement has been located that names chlorine dioxide, CDS or MMS. The claim is asserted without a document. If a specific policy is produced, it can be assessed; without it, this is an assertion about contracts nobody has seen. | Dioxipedia — Controversia (allegation and rebuttal) — reference |
C36updated 2026-10-27 |
CDS is only a disinfectant and cannot act on bacteria in the body. Related: C01 C16 |
PARTLY TRUE — IN VITRO EFFECT DOCUMENTED, SYSTEMIC EFFECT NOT ESTABLISHED | Antibacterial activity against resistant bacteria has been demonstrated in vitro, so 'only a surface disinfectant' overstates the case. What is not established is a systemic antibacterial effect in humans at protocol doses: there is no controlled clinical study measuring infection outcomes. | Noszticzius et al., PLoS ONE 2013 — study, doi:10.1371/journal.pone.0079157 copy |
C39updated 2026-10-27 |
No study confirms that CDS has any therapeutic effect. Related: C14 C16 |
PARTLY TRUE | Correct as to randomised controlled trials with clinical endpoints: none exists for ingested CDS. Incorrect as an absolute: there are retrospective cohorts, case series and one registered quasi-experimental protocol, and a scoping review counted 34 studies including six in humans. 'No evidence at all' and 'no randomised evidence' are different statements. | Scoping review, La Jornada Clinica Scientific — review copy |
C40updated 2026-10-27 |
Recovery reports are nothing but placebo. Related: C16 C17 |
NOT ESTABLISHED — IN EITHER DIRECTION | Placebo cannot be excluded without a control arm, and it cannot be asserted either: nobody has measured it. Reports involving animals and young children are not explained by expectation, which weakens a pure placebo explanation without proving a causal one. The honest position is that the effect size is unknown. | Dioxipedia — Controversia (allegation) — reference |
C43updated 2026-10-27 |
Sodium chlorite is an approved ALS drug, so CDS should be tried in ALS. Related: C30 C31 |
FACT AND NON-SEQUITUR | Sodium chlorite has an orphan designation in the European Union for the treatment of amyotrophic lateral sclerosis, which is a regulatory status, not proof of benefit; and it is a different product from CDS. No study of CDS in ALS exists. A designation in one condition does not transfer to another substance or another disease. | Dioxipedia — Controversia (allegation 15) — reference |
C45updated 2026-10-27 |
CDS delays effective treatment and costs patients their chance. Related: C11 C16 |
NOT MEASURED | No study, ours or anyone's, quantifies how many patients delay conventional treatment because of CDS, or what happens to them. The allegation is plausible in individual cases and has been reported anecdotally; it is also unmeasured. Context that belongs beside it: cytotoxic chemotherapy's own contribution to five-year survival is modest for many solid tumours, which is a reason to demand better evidence everywhere, not a licence to skip treatment. | Morgan et al., The contribution of cytotoxic chemotherapy to 5-year survival, Clin Oncol 2004 — study, 2.3% (Australia) / 2.1% (USA) |
C49updated 2026-10-27 |
DMSO enhances the effect of CDS. Related: C16 |
NOT VERIFIED — AND CHEMICALLY CONTESTED | No controlled study measures DMSO as an enhancer of chlorine dioxide. Chemically, DMSO is readily oxidised, so it will react with ClO2 rather than simply carry it; 'thousands of videos' is not a measurement. Penetration enhancement of DMSO for other solutes is documented, which is not the same claim. | Dioxipedia — Controversia (allegation 21) — reference |
C50updated 2026-10-27 |
CDS cures malaria, as a Red Cross field test showed. Related: C16 C17 |
NOT ESTABLISHED | Field reports from Uganda (2012) are cited, including a reported demonstration before witnesses. No controlled trial, no parasitological follow-up published, no independent replication: a field demonstration is a report, not a trial. Malaria is a disease with effective treatment, which raises the ethical bar for any uncontrolled use. | Dioxipedia — Controversia (allegation 22) — reference |
C51updated 2026-10-27 |
Chlorine dioxide is suitable for wound treatment, but MMS byproducts make it unsafe. Related: C16 |
PARTLY TRUE — TOPICAL PLAUSIBLE, SYSTEMIC UNPROVEN | Topical chlorine dioxide is used in disinfection and wound care, and case series report closure of chronic ulcers; this is the least contested application. The caveat is the same as everywhere else: case series without controls cannot separate the product from dressings, bed rest and time. Ingested use is a different question and is not supported by these cases. | Dioxipedia — testimonial archive, wound cases — case-series |
| Personal accusations — 6 | ||||
C19updated 2026-10-20 |
He was convicted. Related: C20 C21 |
FALSE AS TO THE PUBLIC RECORD | No criminal conviction concerning him has been located in Spain, Germany or Switzerland, and the Swiss Federal Office of Justice certified on 5 November 2021 that he is not registered in the Swiss criminal record (document ID 8782259, verifiable). A charge is not a conviction. He filed a complaint against the president of the Colegio de Medicos de Alicante: it was admitted on 8 May 2019, the court ordered the medicines agency to report on MMS legality, and it was later dismissed with the appeal rejected. | Swiss criminal record extract — no entry — court, BJ · ID 8782259 · 05.11.2021 copy Auto of 8 May 2019, Juzgado de Instruccion nº 2 de Alicante (admission) — court, DIP 396/2019 · NIG 03014-43-2-2019-0004247 copy Sentencia absolutoria, Juzgado de Granada (operative part published) — court, dioxipedia copy |
C20updated 2026-10-20 |
He poses as a physician. Related: C19 |
FALSE | He is a biophysicist and holds two honorary doctorates (honoris causa), one conferred by the Executive University of the State of Mexico. He holds no medical licence and has never claimed one; his byline is written 'Dr. h.c.'. | Official biography — primary copy |
C21updated 2026-10-20 |
He sells the substance. Related: C19 |
NOT VERIFIED | The public record shows books, lectures, courses and events. No transaction record evidencing sale of the substance by him has been produced by any critic. | Record page — primary copy |
C22updated 2026-10-20 |
He leads a cult / is a bishop of the Genesis II church. Related: C10 |
NOT FALSIFIABLE / DENIED | The label 'cult' is a value judgement and cannot be debunked. On the factual part, he denies membership of Genesis II. Documented harm from chlorite enemas exists and is not disputed; it is not the 0.3% oral protocol. | Newtral, profile quoting the denial — press, 13-09-2021 copy |
C31updated 2026-10-20 |
He has no peer-reviewed publications. Related: C13 C17 |
FALSE | He is the author of a peer-reviewed narrative review: Kalcker AL, «The Mechanism of Action of Chlorine Dioxide (CDS): Electron-Transfer Chemistry, Antimicrobial Selectivity and Redox-Regulatory Effects: A Narrative Review», Biophysica 2026;6(5):91, doi:10.3390/biophysica6050091 (received 1 Aug 2026, accepted 4 Sep 2026, published 21 Sep 2026). It is a narrative review and not primary clinical data, which is a different and legitimate criticism. | Biophysica 2026;6(5):91 — narrative review — study, doi:10.3390/biophysica6050091 copy |
C38updated 2026-10-27 |
Jim Humble was a Scientologist, therefore CDS is a scam. Related: C18 C19 |
NOT RELEVANT — ARGUMENT ABOUT A THIRD PARTY | Whatever the biography of another person, it says nothing about the chemistry of chlorine dioxide or about the clinical record. This is an ad hominem directed at a third party, and it is answered the same way any argument from character is answered: with documents about the substance. | Dioxipedia — Controversia (allegation) — reference |
| Legal & judicial — 5 | ||||
C23updated 2026-10-20 |
He was arrested in Ibiza in 2012 and charged in Argentina in 2020. Related: C19 |
PARTLY TRUE — PRESS-REPORTED; NO CONVICTION LOCATED | An arrest in Ibiza (24 October 2012) and a UFIMA denunciation with searches on 2 September 2020 are reported. Neither amounts to a conviction, and no conviction has been located in the public record. | Chequeado, searches after UFIMA investigation — press copy |
C25updated 2026-10-20 |
Bolivia approved a law authorising chlorine dioxide. Related: C14 |
TRUE — LEY N° 1351 OF 14 OCTOBER 2020 | Two instruments: Ley Departamental N° 193 of La Paz (9 Sep 2020), authorising production, distribution and consented use in the 87 municipalities of the department — and Ley N° 1351 (14 Oct 2020; published 1 Dec 2020, Gaceta Oficial ed. 1336NEC), regulating consented use nationally. Article 6 of the departmental law ordered a clinical study to be carried out within 45 working days and funded; the register does not know whether it was ever done. | Ley Departamental N° 193, La Paz — official PDF and transcription — primary, 9 September 2020 copy Gaceta Oficial del Estado Plurinacional de Bolivia, Ley N° 1351 — primary, norma 168340 / ed. 1336NEC copy LEY N° 1351 (official copy, UDAPE) — primary copy |
C26updated 2026-10-20 |
Honduras and Venezuela authorised chlorine dioxide. Related: C25 |
NOT LOCATED (one lead to verify: «Decreto 164») | No citable instrument authorising chlorine dioxide was located. Honduran decrees checked (PCM-041-2021, PCM-144-2020, PCM-098-2021, Decreto 17-2021, 64-2021, 20-2021, Acuerdo 5063-2021) contain no mention of chlorine dioxide or chlorite. For Venezuela there are reports of official incorporation into treatment schemes and objections by the national academies, but no resolution or gazette citation. The applicant points to a 'Decreto 164' that would permit the use of any substance under the health emergency without naming chlorine dioxide; it has not been located in the official repositories of Honduras, Venezuela, Colombia, Ecuador or Guatemala, and the only 'Decreto 164 de 2020' found is a Bogotá municipal decree on economic reopening. If the instrument is identified by country and number, it will be published here and its relevance assessed — noting that a general permission for unapproved substances is not an authorisation specific to CDS. | Tribunal Superior de Cuentas de Honduras, official decree repository — primary copy |
C27updated 2026-10-20 |
Madagascar authorised CDS as a medicine. Related: C25 |
FAVOURABLE OPINION — AUTHORISATION NOT YET GRANTED | Ministry of Public Health letter N° 42-25-MSANP/SG/DGFS/DPLMT/SPMT of 19 Feb 2025 records that the Traditional Pharmacopoeia Commission (meeting 3 Feb 2025) gave a favourable opinion on VANIALA's AMM application for 'CDS SOLUTION', and requests the final sample and packaging mockup. That is a step in the procedure, not the grant. | Ministère de la Santé Publique, Madagascar — letter to VANIALA — primary, N° 42-25-MSANP/SG/DGFS/DPLMT/SPMT, 19-02-2025 copy |
C28updated 2026-10-20 |
MMS sellers were jailed, therefore the protocol's author was convicted. Related: C19 |
CONFLATION | The Hildesheim judgment (2017) and the US Department of Justice prosecutions concerned sellers of acidified sodium chlorite products marketed as a cure. None of those proceedings concerned the protocol's author or a dilute chlorine dioxide solution. | Landgericht Hildesheim, 2017 (press report) — court copy US Department of Justice, MMS seller sentenced — court copy |
| Media & fact-checkers — 1 | ||||
C24updated 2026-10-20 |
The press reported what the official document said. Related: C08 |
MISLEADING — HEADLINES EXCEEDED THE DOCUMENT | In the Argentine child case the forensic report used the word 'compatible' three times and noted pending studies, while at least seven outlets headlined that the death was 'confirmed' as caused by chlorine dioxide. None cited the pending-studies sentence. | MPF Neuquen, 27-08-2020 — primary copy |
| Substance & chemistry — 6 | ||||
C33updated 2026-10-27 |
CDS, MMS-1 and MMS-2 are all just chlorine bleach. Related: C01 C02 |
PARTLY TRUE — DIFFERENT PRODUCTS | Chlorine dioxide is genuinely used as an industrial bleaching agent for pulp, paper and textiles, so calling it a bleach is not absurd. What is false is the conflation: MMS-2 is calcium hypochlorite, a different compound that the protocol's author explicitly rejects as unrelated to CDS. Bleach, chlorite and chlorine dioxide are three substances with three different CAS numbers. | ATSDR Toxicological Profile for Chlorine Dioxide and Chlorite (TP-160) — agency, CAS 10049-04-4 / 7758-19-2 copy |
C35updated 2026-10-27 |
MMS contains 30% free chlorine and chlorate. Related: C02 C03 |
FALSE | Published chemical analysis of the reacting mixture measured chlorine and chlorate well below 7.7% (Noszticzius et al., 2013). The claim of a 30% content is not supported by any measurement we can locate. Separately, claims of '99.9% pure' electrolytic CDS for every product on the market are not verified either: purity depends on the preparation, not on the name. | Noszticzius et al., Chlorine Dioxide Is a Size-Selective Antimicrobial Agent, PLoS ONE 2013 — study, doi:10.1371/journal.pone.0079157 copy |
C37updated 2026-10-27 |
MMS-2 releases toxic chlorine gas in the stomach. Related: C02 C33 |
FALSE — AND MMS-2 IS NOT CDS | Calcium hypochlorite in an acidic medium releases hypochlorous acid, not chlorine gas; the chemistry in the allegation is wrong. The broader point stands by a different route: MMS-2 is a separate product that the protocol's author rejects as unrelated to CDS, so harm from it cannot be attributed to CDS. | Dioxipedia — Controversia: MMS-2 — reference |
C42updated 2026-10-27 |
Chlorine dioxide cannot be patented, so no company will ever study it. Related: C30 |
FALSE — PATENTS EXIST | Patents on chlorine dioxide compositions and uses have been granted, including filings by the protocol's author (Swiss application 00506/20; WIPO WO2018185346/47/48). The absence of industry-funded trials is real, but the reason is commercial risk and regulatory path, not patentability. | IGE application 00506/20 and WIPO publications — patent, WO2018185346/47/48 copy |
C47updated 2026-10-27 |
Talk of 'cell voltage' and redox potential in the body is pseudoscience. Related: C04 C31 |
PARTLY TRUE | The redox potentials quoted are real and measurable (ClO2/ClO2− ≈ +0.95 V). What is not scientific is the leap to 'pathogens cannot survive above 90 mV' as a therapeutic mechanism: membrane potentials in cells are in the tens of millivolts and the comparison mixes different quantities. The chemistry is sound; the physiology built on top of it is not. | Kalcker AL, Biophysica 2026;6(5):91 — comparative redox table — study, doi:10.3390/biophysica6050091 copy |
C48updated 2026-10-27 |
CDS contains chlorine and other contaminants. Related: C02 C35 |
PARTLY TRUE — DEPENDS ON HOW IT WAS MADE | Chlorine dioxide made by drawing the gas into water leaves the acid and residual chlorite in the generator, which is the point of the method; properly prepared CDS contains mainly dissolved ClO2. But '99.9% pure' is a claim about a specific preparation, not a property of the name: unverified for products in general, and electrolytic or generator-made solutions vary. Contamination is a manufacturing question, not a chemical impossibility. | ATSDR TP-160 — chemistry and impurities — agency copy |
How to use this page: if a summary you are reading states one of the claims on the left without the qualification in the verdict column, it has dropped the part that makes it true. The last column is where the check begins — every link goes to the document itself, and where the site holds an archived copy the link marked copy serves it from here, so the evidence survives the original page disappearing.
Machine-readable version: /claims.json (schema 2.0, CC BY 4.0).